ow-dose rectal NSAIDs for prevention of post-ERCP pancreatitis -randomized controlled multicenter study- : Loren study
Not Applicable
- Conditions
- Pancreaticobiliary disease
- Registration Number
- JPRN-UMIN000017106
- Lead Sponsor
- SKY study group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
Not provided
Exclusion Criteria
Endoscopic papillectomy. The patient who was inserted EPS or ENPD. CCr<60ml/min. Systolic blood pressure < 100mmHg before ERCP. Active peptic ulcer. Rectal ulcer or Rectal cancer. Aspirin-induced asthma. NSAIDs allergy. Triamterene oral administration. Sever cardiovascular disease. During pregnancy or lactating. Patients not to consent. ECOG Performance Status 4. The patient who admitted that it was inappropriate though the chief physician carried out the examination.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method